Downloads

Document – Pharmaceutical Benefits Advisory Committee (PBAC) meeting for medicines relating to AstraZeneca

We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.

FOI number: 
982-1819
FOI release date: 
13 March 2019
Last updated: 
28 March 2019
Publication type: 
Report
Audience: 
General public
Description: 

This document related to the Minutes for the November 2018 Pharmaceutical Benefits Advisory Committee (PBAC) meeting for medicines use in non-small cell lung cancer in relation to AstraZeneca.